These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 23535161

  • 1. Cutting edge in myasthenia gravis.
    Berrih-Aknin S, Souroujon MC.
    Autoimmun Rev; 2013 Jul; 12(9):861-2. PubMed ID: 23535161
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Myasthenia gravis: immune mechanisms and implications.
    Newsom-Davis J.
    Clin Exp Neurol; 1981 Jul; 18():14-26. PubMed ID: 6984827
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Myasthenia gravis (first of two parts).
    Drachman DB.
    N Engl J Med; 1978 Jan 19; 298(3):136-42. PubMed ID: 201840
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Physiopathology of myasthenia gravis. A review (author's transl)].
    Bergmans J.
    Ann Chir; 1980 Mar 19; 34(3):147-57. PubMed ID: 6245616
    [No Abstract] [Full Text] [Related]

  • 10. [Conceptual aspects of myasthenia gravis].
    Ledro Molina D, Avilés Mejías S, Garrido Peralta M.
    Rev Clin Esp; 1981 Oct 15; 163(1):13-6. PubMed ID: 6276939
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical study of autoimmune diseases: recent trends--with special reference to progress in immunological tests and therapeutic methods. Organ-specific autoimmune diseases. 3) Myasthenia gravis].
    Arimori S.
    Nihon Rinsho; 1988 Apr 15; 46(4):907-11. PubMed ID: 3404711
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Myasthenia gravis: a model disorder of acetylcholine receptors.
    Drachman DB.
    Res Publ Assoc Res Nerv Ment Dis; 1987 Apr 15; 65():65-82. PubMed ID: 3330842
    [No Abstract] [Full Text] [Related]

  • 14. Progress in myasthenia gravis.
    Havard CW.
    Br Med J; 1977 Oct 15; 2(6093):1008-11. PubMed ID: 336138
    [No Abstract] [Full Text] [Related]

  • 15. [Myasthenia gravis and its immunological aspects].
    Kinoshita M, Okada S, Oyamatu T, Iguchi H.
    No To Shinkei; 1993 Oct 15; 45(10):909-16. PubMed ID: 8268030
    [No Abstract] [Full Text] [Related]

  • 16. [Myasthenia gravis: pathogenesis elucidated. Aetiology and relationship with thymus still unknown (author's transl)].
    de Crousaz G.
    Schweiz Rundsch Med Prax; 1977 Jan 25; 66(4):103-6. PubMed ID: 299944
    [No Abstract] [Full Text] [Related]

  • 17. Myasthenia gravis: an example of receptor disease.
    Conti-Tronconi BM, Fumagalli G, Scotti A, Brigonzi A, Sher E, Morgutti M, Clementi F.
    Adv Biochem Psychopharmacol; 1980 Jan 25; 21():473-88. PubMed ID: 7376974
    [No Abstract] [Full Text] [Related]

  • 18. Factors influencing the clinical type and course of myasthenia gravis.
    Hayashi M, Kida K, Sonoda S, Inoue H, Matsuda H.
    Brain Dev; 1992 Mar 25; 14(2):88-93. PubMed ID: 1621931
    [Abstract] [Full Text] [Related]

  • 19. Rational therapy of myasthenia gravis.
    Finley JC, Pascuzzi RM.
    Semin Neurol; 1990 Mar 25; 10(1):70-82. PubMed ID: 2189183
    [No Abstract] [Full Text] [Related]

  • 20. [Anti-acetylcholine receptor antibodies and myasthenia gravis (author's transl)].
    Nishitani H.
    Nihon Naika Gakkai Zasshi; 1980 Dec 25; 69(12):1578-83. PubMed ID: 7229476
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.